日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/04/20 | 5,147 | 5,190 | 5,078 | 5,105 | +13 | +0.3% | 159,000 |
| 2026/04/17 | 5,104 | 5,131 | 5,082 | 5,092 | -49 | -1% | 191,700 |
| 2026/04/16 | 5,192 | 5,211 | 5,100 | 5,141 | -19 | -0.4% | 142,700 |
| 2026/04/15 | 5,189 | 5,239 | 5,148 | 5,160 | +24 | +0.5% | 127,700 |
| 2026/04/14 | 5,149 | 5,171 | 5,100 | 5,136 | +35 | +0.7% | 203,500 |
| 2026/04/13 | 5,110 | 5,129 | 5,076 | 5,101 | -51 | -1% | 190,400 |
| 2026/04/10 | 5,200 | 5,297 | 5,129 | 5,152 | -91 | -1.7% | 189,700 |
| 2026/04/09 | 5,323 | 5,334 | 5,243 | 5,243 | -51 | -1% | 113,900 |
| 2026/04/08 | 5,414 | 5,420 | 5,292 | 5,294 | -20 | -0.4% | 188,300 |
| 2026/04/07 | 5,296 | 5,345 | 5,261 | 5,314 | +18 | +0.3% | 180,600 |
| 2026/04/06 | 5,335 | 5,340 | 5,273 | 5,296 | -15 | -0.3% | 90,600 |
| 2026/04/03 | 5,273 | 5,318 | 5,225 | 5,311 | +16 | +0.3% | 171,100 |
| 2026/04/02 | 5,397 | 5,406 | 5,285 | 5,295 | -86 | -1.6% | 221,700 |
| 2026/04/01 | 5,250 | 5,381 | 5,212 | 5,381 | +268 | +5.2% | 223,300 |
| 2026/03/31 | 5,165 | 5,229 | 5,113 | 5,113 | -52 | -1% | 216,000 |
| 2026/03/30 | 5,098 | 5,263 | 5,066 | 5,165 | -202 | -3.8% | 379,100 |
| 2026/03/27 | 5,312 | 5,367 | 5,280 | 5,367 | +75 | +1.4% | 357,000 |
| 2026/03/26 | 5,262 | 5,346 | 5,258 | 5,292 | +62 | +1.2% | 276,500 |
| 2026/03/25 | 5,227 | 5,274 | 5,225 | 5,230 | +69 | +1.3% | 282,600 |
| 2026/03/24 | 5,161 | 5,230 | 5,070 | 5,161 | +235 | +4.8% | 431,500 |
| 2026/03/23 | 5,045 | 5,121 | 4,926 | 4,926 | -87 | -1.7% | 493,300 |
| 2026/03/19 | 5,090 | 5,139 | 5,012 | 5,013 | -208 | -4% | 509,500 |
| 2026/03/18 | 5,205 | 5,226 | 5,160 | 5,221 | -21 | -0.4% | 263,900 |
| 2026/03/17 | 5,232 | 5,306 | 5,184 | 5,242 | +7 | +0.1% | 239,000 |
| 2026/03/16 | 5,460 | 5,467 | 5,175 | 5,235 | -237 | -4.3% | 377,900 |
| 2026/03/13 | 5,344 | 5,499 | 5,329 | 5,472 | +60 | +1.1% | 391,300 |
| 2026/03/12 | 5,601 | 5,601 | 5,335 | 5,412 | -198 | -3.5% | 472,400 |
| 2026/03/11 | 5,451 | 5,626 | 5,404 | 5,610 | +320 | +6% | 749,300 |
| 2026/03/10 | 5,127 | 5,290 | 5,066 | 5,290 | +163 | +3.2% | 375,700 |
| 2026/03/09 | 4,834 | 5,148 | 4,825 | 5,127 | +223 | +4.5% | 626,500 |
| 2026/03/06 | 4,834 | 4,904 | 4,781 | 4,904 | ±0 | ±0% | 207,800 |
| 2026/03/05 | 4,905 | 4,965 | 4,887 | 4,904 | +69 | +1.4% | 229,400 |
| 2026/03/04 | 4,912 | 4,925 | 4,747 | 4,835 | -165 | -3.3% | 419,900 |
| 2026/03/03 | 5,076 | 5,125 | 5,000 | 5,000 | -127 | -2.5% | 330,600 |
| 2026/03/02 | 5,158 | 5,207 | 5,100 | 5,127 | -17 | -0.3% | 293,300 |
| 2026/02/27 | 5,096 | 5,166 | 5,081 | 5,144 | +48 | +0.9% | 264,900 |
| 2026/02/26 | 5,081 | 5,104 | 5,034 | 5,096 | +81 | +1.6% | 257,300 |
| 2026/02/25 | 5,029 | 5,065 | 4,955 | 5,015 | +19 | +0.4% | 240,600 |
| 2026/02/24 | 4,960 | 5,033 | 4,857 | 4,996 | -19 | -0.4% | 330,200 |
| 2026/02/20 | 5,075 | 5,075 | 5,005 | 5,015 | -48 | -0.9% | 263,300 |
| 2026/02/19 | 4,910 | 5,063 | 4,909 | 5,063 | +98 | +2% | 313,300 |
| 2026/02/18 | 4,931 | 4,965 | 4,902 | 4,965 | +85 | +1.7% | 188,800 |
| 2026/02/17 | 5,000 | 5,000 | 4,866 | 4,880 | -120 | -2.4% | 258,200 |
| 2026/02/16 | 5,004 | 5,092 | 4,970 | 5,000 | +22 | +0.4% | 284,400 |
| 2026/02/13 | 5,008 | 5,041 | 4,941 | 4,978 | -26 | -0.5% | 364,700 |
| 2026/02/12 | 5,130 | 5,158 | 5,004 | 5,004 | -154 | -3% | 400,000 |
| 2026/02/10 | 5,132 | 5,222 | 5,067 | 5,158 | +48 | +0.9% | 326,500 |
| 2026/02/09 | 5,142 | 5,164 | 4,975 | 5,110 | +68 | +1.3% | 371,700 |
| 2026/02/06 | 5,108 | 5,132 | 5,008 | 5,042 | -138 | -2.7% | 366,500 |
| 2026/02/05 | 5,200 | 5,242 | 5,145 | 5,180 | +29 | +0.6% | 245,400 |
51～
100
件表示中 / 3977件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 413,600円 | +17.1% | +5.9% | 3.00% | 9.20倍 | 0.95倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 154,950円 | +19.1% | -10.3% | 0.00% | 9.03倍 | 2.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ロート | 239,800円 | +7.5% | -3.9% | 2.09% | 15.71倍 | 1.79倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| ツムラ | 379,800円 | +10.9% | -11.3% | 4.16% | 10.80倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 東和薬品 | 419,500円 | +11.1% | +6.8% | 2.03% | 9.61倍 | 1.15倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
